Published in BMJ on June 23, 2011
Research into practice: management of atrial fibrillation in general practice. Br J Gen Pract (2014) 1.47
Prospective national study of the prevalence, incidence, management and outcome of a large contemporary cohort of patients with incident non-valvular atrial fibrillation. J Am Heart Assoc (2015) 0.99
Novel oral anticoagulants for stroke prevention in atrial fibrillation: a focus on the older patient. Int J Gen Med (2013) 0.83
Stroke prevention with oral anticoagulation in older people with atrial fibrillation - a pragmatic approach. Aging Dis (2012) 0.82
Patient self-management of oral anticoagulation with vitamin K antagonists in everyday practice: efficacy and safety in a nationwide long-term prospective cohort study. PLoS One (2014) 0.80
Impact of Triple Therapy in Elderly Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention. PLoS One (2016) 0.76
Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med (2009) 39.97
Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke (1991) 22.23
Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation. JAMA (2001) 16.98
Apixaban in patients with atrial fibrillation. N Engl J Med (2011) 9.97
A risk score for predicting stroke or death in individuals with new-onset atrial fibrillation in the community: the Framingham Heart Study. JAMA (2003) 4.77
Screening versus routine practice in detection of atrial fibrillation in patients aged 65 or over: cluster randomised controlled trial. BMJ (2007) 3.30
A survey of atrial fibrillation in general practice: the West Birmingham Atrial Fibrillation Project. Br J Gen Pract (1997) 3.29
Anticoagulant use for atrial fibrillation in the elderly. J Am Geriatr Soc (2004) 3.13
Screening for atrial fibrillation in primary care. Heart (1998) 3.02
Oral anticoagulants vs aspirin in nonvalvular atrial fibrillation: an individual patient meta-analysis. JAMA (2002) 2.94
Comparison of risk stratification schemes to predict thromboembolism in people with nonvalvular atrial fibrillation. J Am Coll Cardiol (2008) 2.93
Low-dose aspirin for prevention of stroke in low-risk patients with atrial fibrillation: Japan Atrial Fibrillation Stroke Trial. Stroke (2005) 2.56
Mortality trends in patients diagnosed with first atrial fibrillation: a 21-year community-based study. J Am Coll Cardiol (2007) 2.32
A clinical prediction rule to identify patients with atrial fibrillation and a low risk for stroke while taking aspirin. Arch Intern Med (2003) 2.04
Stroke prophylaxis in atrial fibrillation: who gets it and who does not? Report from the Stockholm Cohort-study on Atrial Fibrillation (SCAF-study). Eur Heart J (2006) 1.91
Comparison of 12 risk stratification schemes to predict stroke in patients with nonvalvular atrial fibrillation. Stroke (2008) 1.71
The safety and adequacy of antithrombotic therapy for atrial fibrillation: a regional cohort study. Br J Gen Pract (2006) 1.47
Atrial fibrillation and stroke prevention. Lancet Neurol (2007) 1.29
Oral anticoagulants for preventing stroke in patients with non-valvular atrial fibrillation and no previous history of stroke or transient ischemic attacks. Cochrane Database Syst Rev (2005) 1.24
Patterns and predictors of warfarin use in patients with new-onset atrial fibrillation from the FRACTAL Registry. Am J Cardiol (2006) 1.13
Pre-admission warfarin use in patients with acute ischemic stroke and atrial fibrillation: The appropriate use and barriers to oral anticoagulant therapy. Thromb Res (2007) 1.11
Evidence for age and sex differences in the secondary prevention of stroke in Scottish primary care. Stroke (2005) 1.06
Outpatient use of anticoagulants, rate-controlling drugs, and antiarrhythmic drugs for atrial fibrillation. Am Heart J (2007) 0.93
Warfarin use in atrial fibrillation: A random sample survey of family physician beliefs and preferences. Can J Clin Pharmacol (2002) 0.93
Is treatment of atrial fibrillation in primary care based on thromboembolic risk assessment? Fam Pract (2003) 0.90
Risk factors for stroke and thromboprophylaxis in atrial fibrillation: what happens in daily clinical practice? The GEFAUR-1 study. Ann Emerg Med (2004) 0.89
Late-breaking clinical trials presented at the American Heart Association Congress in Chicago 2010. Clin Res Cardiol (2010) 0.85
Implementation of anticoagulation guidelines in general practice: a practice report. Ir Med J (2004) 0.83
Adherence to clinical guidance in the prescribing of oral antithrombotic medication in patients with atrial fibrillation. Ir J Med Sci (2006) 0.78
WITHDRAWN: Antiplatelet therapy for preventing stroke in patients with nonrheumatic atrial fibrillation and a history of stroke or transient ischemic attacks. Cochrane Database Syst Rev (1996) 0.77
Prevalence of left-ventricular systolic dysfunction and heart failure in the Echocardiographic Heart of England Screening study: a population based study. Lancet (2001) 4.12
Development of symptoms of tobacco dependence in youths: 30 month follow up data from the DANDY study. Tob Control (2002) 3.64
Impact of heart failure and left ventricular systolic dysfunction on quality of life: a cross-sectional study comparing common chronic cardiac and medical disorders and a representative adult population. Eur Heart J (2002) 2.96
Bipyridylium quaternary salts and related compounds. V. Pulse radiolysis studies of the reaction of paraquat radical with oxygen. Implications for the mode of action of bipyridyl herbicides. Biochim Biophys Acta (1973) 2.56
A randomised controlled trial and cost-effectiveness study of systematic screening (targeted and total population screening) versus routine practice for the detection of atrial fibrillation in people aged 65 and over. The SAFE study. Health Technol Assess (2005) 2.42
Targets and self monitoring in hypertension: randomised controlled trial and cost effectiveness analysis. BMJ (2005) 2.41
Executive functioning, temporal discounting, and sense of time in adolescents with attention deficit hyperactivity disorder (ADHD) and oppositional defiant disorder (ODD). J Abnorm Child Psychol (2001) 2.27
Monitoring oral anticoagulation in primary care. BMJ (1996) 2.27
Paraquat and related bipyridyls. Br Med Bull (1969) 2.27
Review of the usefulness of contacting other experts when conducting a literature search for systematic reviews. BMJ (1998) 2.25
Three-year follow-up and clinical implications of a mindfulness meditation-based stress reduction intervention in the treatment of anxiety disorders. Gen Hosp Psychiatry (1995) 2.24
A review of near patient testing in primary care. Health Technol Assess (1997) 2.22
Fibrinogen: biochemistry, epidemiology and determinants. QJM (2003) 2.05
Antithrombotic therapy in hypertension: a Cochrane Systematic review. J Hum Hypertens (2005) 2.05
The Birmingham Rehabilitation Uptake Maximisation study (BRUM): a randomised controlled trial comparing home-based with centre-based cardiac rehabilitation. Heart (2008) 2.03
Cardiovascular risk in patients with sleep apnoea with or without continuous positive airway pressure therapy: follow-up of 4.5 million Danish adults. J Intern Med (2014) 1.86
Risk factors for anticoagulation-related bleeding complications in patients with atrial fibrillation: a systematic review. QJM (2007) 1.76
Stroke prevention in atrial fibrillation. BMJ (1997) 1.74
Oral contraception and eye disease: findings in two large cohort studies. Br J Ophthalmol (1998) 1.63
A comparison of risk stratification schemes for stroke in 79,884 atrial fibrillation patients in general practice. J Thromb Haemost (2011) 1.62
Comparison of efficacy and safety of dabigatran, rivaroxaban and apixaban in patients with atrial fibrillation using network meta-analysis. Int Angiol (2012) 1.60
Systematic review of near patient test evaluations in primary care. BMJ (1999) 1.57
The London handicap scale: a re-evaluation of its validity using standard scoring and simple summation. J Neurol Neurosurg Psychiatry (2000) 1.56
Systematic review and individual patient data meta-analysis of diagnosis of heart failure, with modelling of implications of different diagnostic strategies in primary care. Health Technol Assess (2009) 1.55
High sensitivity cardiac troponin T and interleukin-6 predict adverse cardiovascular events and mortality in anticoagulated patients with atrial fibrillation. J Thromb Haemost (2012) 1.55
Matrix metalloproteinase-1 and its inhibitor, TIMP-1, in systolic heart failure: relation to functional data and prognosis. J Intern Med (2007) 1.53
Changes in the composition of lung lipids and the "turnover" of dipalmitoyl lecithin in experimental alveolar lipo-proteinosis induced by inhaled quartz. Br J Exp Pathol (1974) 1.53
Increased 5-year mortality in the migrant South Asian stroke patients with diabetes mellitus in the United Kingdom: the West Birmingham Stroke Project. Int J Clin Pract (2007) 1.50
Matrix metalloproteinases and their tissue inhibitors in hypertension-related pregnancy complications. J Hum Hypertens (2012) 1.49
The effectiveness of exercise as treatment for vasomotor menopausal symptoms: randomised controlled trial. BJOG (2014) 1.48
Heart failure: Diagnosis of heart failure in primary care. Heart (2010) 1.45
Angiogenin: a review of the pathophysiology and potential clinical applications. J Thromb Haemost (2006) 1.45
A systematic review of the evidence for rapid access chest pain clinics. Int J Clin Pract (2002) 1.44
New B-type cyclin synthesis is required between meiosis I and II during Xenopus oocyte maturation. Development (2001) 1.44
Is context everything to the definition of clinical depression? A test of the Horwitz and Wakefield postulate. J Affect Disord (2010) 1.42
Should oral glucose tolerance testing be mandatory following acute myocardial infarction? Int J Clin Pract (2007) 1.41
Comparative amnestic effects of benzodiazepine hypnotic agents. J Clin Psychiatry (1988) 1.41
Circulating endothelial cells, endothelial progenitor cells, and endothelial microparticles in cancer. Neoplasia (2006) 1.41
Obstructive sleep apnoea and metabolic syndrome: two sides of the same coin? J Hum Hypertens (2008) 1.39
The Birmingham Rehabilitation Uptake Maximisation Study (BRUM). Home-based compared with hospital-based cardiac rehabilitation in a multi-ethnic population: cost-effectiveness and patient adherence. Health Technol Assess (2007) 1.39
Mortality study of 18 000 patients treated with omeprazole. Gut (2003) 1.39
Written information for treating minor illness. BMJ (2001) 1.32
Circulating microparticles in cardiovascular disease: implications for atherogenesis and atherothrombosis. J Thromb Haemost (2010) 1.32
Can computerised decision support systems deliver improved quality in primary care?. Interview by Abi Berger. BMJ (1999) 1.31
Immunophenotypic characterization of human monocyte subsets: possible implications for cardiovascular disease pathophysiology. J Thromb Haemost (2011) 1.31
Multi-method psycho-educational intervention for preschool children with disruptive behavior: preliminary results at post-treatment. J Child Psychol Psychiatry (2000) 1.27
The efficacy of problem-solving communication training alone, behavior management training alone, and their combination for parent-adolescent conflict in teenagers with ADHD and ODD. J Consult Clin Psychol (2001) 1.25
The perceptions and practices of pediatricians: tobacco intervention. Pediatrics (1999) 1.24
Where should oral anticoagulation monitoring take place? Br J Gen Pract (1997) 1.24
Bleeding risk in 'real world' patients with atrial fibrillation: comparison of two established bleeding prediction schemes in a nationwide cohort. J Thromb Haemost (2011) 1.23
Prevalence of left ventricular systolic dysfunction and heart failure in high risk patients: community based epidemiological study. BMJ (2002) 1.22
Plasma angiopoietin-1, angiopoietin-2 and Tie-2 in breast and prostate cancer: a comparison with VEGF and Flt-1. Eur J Clin Invest (2003) 1.19
Peripheral vascular disease and Virchow's triad for thrombogenesis. QJM (2002) 1.19
Impact of study design on recruitment of patients to a primary care trial: an observational time series analysis of the Birmingham Atrial Fibrillation Treatment of the Aged (BAFTA) study. Fam Pract (2010) 1.19
What do stroke patients and their carers want from community services? Fam Pract (2005) 1.18
Parent-adolescent conflict in teenagers with ADHD and ODD. J Abnorm Child Psychol (2001) 1.14
Rate control in the medical management of atrial fibrillation. Heart (2006) 1.13
A primary care evaluation of three near patient coagulometers. J Clin Pathol (1999) 1.13
Ethnic differences in blood pressure and the prevalence of hypertension in England. J Hum Hypertens (2002) 1.12
The CD14++CD16+ monocyte subset and monocyte-platelet interactions in patients with ST-elevation myocardial infarction. J Thromb Haemost (2012) 1.11
Lack of activity of estradiol in rodent bone marrow micronucleus assays. Mutat Res (1997) 1.09
The potential impact of periodontal disease on general health: a consensus view. Curr Med Res Opin (2008) 1.09
Impact of age and sex on primary preventive treatment for cardiovascular disease in the West Midlands, UK: cross sectional study. BMJ (2012) 1.08
Continuous ambulatory peritoneal dialysis after the honeymoon: review of experience in Newcastle 1979-84. Br Med J (Clin Res Ed) (1986) 1.08
Plasma vascular endothelial growth factor, angiopoietin-2, and soluble angiopoietin receptor tie-2 in diabetic retinopathy: effects of laser photocoagulation and angiotensin receptor blockade. Br J Ophthalmol (2004) 1.07
Getting research into practice: facing the issues. J Manag Med (1994) 1.07
Angiogenesis, thrombogenesis, endothelial dysfunction and angiographic severity of coronary artery disease. Heart (2003) 1.06
Policy dilemmas for oral anticoagulation management. Br J Gen Pract (2000) 1.02
Assessment of endothelial damage and dysfunction: observations in relation to heart failure. QJM (2003) 1.02
Abnormalities of lung lipids following inhalation of quartz. Experientia (1972) 1.01
Circulating endothelial cells: markers of vascular dysfunction. Clin Lab (2005) 1.00
Comparison of the CHADS2, CHA2DS2-VASc and HAS-BLED scores for the prediction of clinically relevant bleeding in anticoagulated patients with atrial fibrillation: the AMADEUS trial. Thromb Haemost (2013) 1.00
Biomarkers in atrial fibrillation: an overview. Int J Clin Pract (2013) 0.99
Is the international normalised ratio (INR) reliable? A trial of comparative measurements in hospital laboratory and primary care settings. J Clin Pathol (1999) 0.99
Lone atrial fibrillation - an overview. Int J Clin Pract (2013) 0.98
The role of omega-3 fatty acids in the secondary prevention of cardiovascular disease. QJM (2003) 0.96
The composition of lung lipids after poisoning with paraquat. Br J Exp Pathol (1970) 0.96
Reliability of N-terminal proBNP assay in diagnosis of left ventricular systolic dysfunction within representative and high risk populations. Heart (2004) 0.95
Quality of life in adults with congenital heart disease. Heart (2002) 0.95
Retinal vein and artery occlusions: a risk factor for stroke in atrial fibrillation. J Thromb Haemost (2013) 0.95
Combined oral contraceptives and liver disease. Contraception (1997) 0.94
Systolic vs diastolic blood pressure and the burden of hypertension. J Hum Hypertens (2002) 0.94
Factors predicting the development of metabolic syndrome and type II diabetes against a background of hypertension. Eur J Clin Invest (2005) 0.94
An in vitro model system to study gene therapy in the human inner ear. Gene Ther (2007) 0.94
Point of care testing for INR monitoring: where are we now? Br J Haematol (2004) 0.94
Lone atrial fibrillation: what is known and what is to come. Int J Clin Pract (2011) 0.94
Admissions with atrial fibrillation in a multiracial population in Kuala Lumpur, Malaysia. Int J Cardiol (2003) 0.93
Clinically apparent atherosclerotic disease in diabetes is associated with an increase in platelet microparticle levels. Diabet Med (2005) 0.93
Compliance with pharmacological therapy in hypertension: can we do better, and how? J Hum Hypertens (2004) 0.92
Collateralization and the response to obstruction of epicardial coronary arteries. QJM (2004) 0.92
Treating depression with the evidence-based psychotherapies: a critique of the evidence. Acta Psychiatr Scand (2007) 0.92